Get the Stockscreener App
2.535
10.42%
-0.295
After Hours:
2.51
-0.025
-0.99%
C 4 Therapeutics Inc Stock (CCCC) Forecast
The C 4 Therapeutics Inc (CCCC) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.9975, representing a -60.65% decrease from the current price of $2.535. The highest analyst price target is $1.5486, and the lowest is $0.4464.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CCCC Price Target
Average 3.1137
(+22.83% Upside)
Is C 4 Therapeutics Inc (CCCC) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 46.25 | Neutral |
| STOCH(9,6) | 70.04 | Neutral |
| STOCHRSI(14) | 25.34 | Neutral |
| MACD(12,26) | 0.037 | Sell |
| ADX(14) | 27.35 | Buy |
| William %R | -67.36 | Neutral |
| CCI(14) | -14.73 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.6755
Sell
|
2.7092
Sell
|
| MA20 |
2.6668
Sell
|
2.6907
Sell
|
| MA50 |
2.4873
Buy
|
2.5714
Sell
|
| MA100 |
2.3886
Buy
|
2.4666
Buy
|
| MA200 |
2.3707
Buy
|
2.437
Buy
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, CCCC could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 6 signaling Sell signals and 5 Neutral signals. This suggests that investors should exercise caution when entering new positions on CCCC, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 46.25 indicates that CCCC is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 70.04 indicates that CCCC is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 25.34 indicates that CCCC is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 27.35 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -14.73 indicates that CCCC is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term CCCC price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about C 4 Therapeutics Inc financial reports and earnings history, C 4 Therapeutics Inc (CCCC) stock could reach $16.88 by 2030, $18.02 by 2040 and $80.31 by 2050. See the projected annual prices until 2050 of the C 4 Therapeutics Inc stock below:
- C 4 Therapeutics Inc (CCCC) is expected to reach an average price of $24.21 in 2035, with a high prediction of $23.55 and a low estimate of $23.37. This indicates an $855.05% rise from the last recorded price of $2.535.
- C 4 Therapeutics Inc (CCCC) stock is projected to chart a bullish course in 2040, with an average price target of $18.20, representing an $617.90% surge from its current level. The forecast ranges from a conservative $18.33 to a sky-high $18.02.
- Our analysts predict C 4 Therapeutics Inc (CCCC) to jump 2,246% by 2045, soaring from $58.45 to an average price of $59.47, potentially reaching $59.61. While $58.45 is the low estimate, the potential upside is significant.
- C 4 Therapeutics Inc (CCCC) stock is expected to climb by 2050, reaching an average of $81.07, a $3,098% jump from its current level. However, a wide range of estimates exists, with high and low targets of $80.31 and $81.27, respectively, highlighting the market's uncertainty.
C 4 Therapeutics Inc Stock (CCCC) Year by Year Forecast
C 4 Therapeutics Inc Stock (CCCC) Price Forecast for 2026
The predicted value for C 4 Therapeutics Inc (CCCC) in 2026 is set at an average of $3.4878. Estimates vary from a peak of $6.5291 to a trough of $0.4464, indicating an +37.58% surge from the present price of $2.535.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2026 | $0.6047 | $0.4464 | $1.5486 | -76.15% |
| June, 2026 | $1.4713 | $1.6089 | $1.3187 | -41.96% |
| July, 2026 | $2.2521 | $2.9346 | $2.548 | -11.16% |
| August, 2026 | $1.6588 | $1.5504 | $1.2988 | -34.57% |
| September, 2026 | $2.5195 | $1.7929 | $1.8095 | -0.61% |
| October, 2026 | $3.3862 | $3.3937 | $4.077 | +33.58% |
| November, 2026 | $2.0528 | $2.2928 | $1.7828 | -19.02% |
| December, 2026 | $4.2436 | $2.9369 | $4.0786 | +67.40% |
C 4 Therapeutics Inc Stock (CCCC) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for C 4 Therapeutics Inc (CCCC) is $2.9183, with a high forecast of $5.781 and a low forecast of $0.0555. This indicates an +15.12% increase from the last price of $2.535.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $5.7102 | $4.7577 | $5.0502 | +125.25% |
| February, 2027 | $5.6968 | $5.8668 | $5.781 | +124.73% |
| March, 2027 | $5.5776 | $5.6393 | $5.601 | +120.02% |
| April, 2027 | $5.0242 | $5.0392 | $5.1318 | +98.19% |
| May, 2027 | $4.7808 | $4.8408 | $5.2825 | +88.59% |
| June, 2027 | $4.3916 | $4.1633 | $4.1951 | +73.24% |
| July, 2027 | $4.6583 | $4.5208 | $4.5683 | +83.76% |
| August, 2027 | $5.4149 | $5.1966 | $5.2249 | +113.60% |
| September, 2027 | $5.4557 | $5.3173 | $5.3857 | +115.21% |
| October, 2027 | $5.1523 | $5.1481 | $5.2398 | +103.25% |
| November, 2027 | $1.4689 | $5.0806 | $4.9506 | -42.05% |
| December, 2027 | $0.1797 | $0.0555 | $2.2645 | -92.91% |
C 4 Therapeutics Inc Stock (CCCC) Price Forecast for 2028
In 2028, C 4 Therapeutics Inc (CCCC) is projected to reach an average price of $7.0837, with a high projection of $14.01 and a low estimate of $0.1536. This indicates an +179.43% rise from the last price of $2.535.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.3237 | $0.453 | $0.4319 | -87.23% |
| February, 2028 | $5.4271 | $0.2995 | $5.7412 | +114.09% |
| March, 2028 | $2.2863 | $2.2063 | $6.3829 | -9.81% |
| April, 2028 | $1.3296 | $1.0838 | $2.9121 | -47.55% |
| May, 2028 | $10.80 | $1.3155 | $11.17 | +326.23% |
| June, 2028 | $2.2782 | $2.4149 | $5.2633 | -10.13% |
| July, 2028 | $2.8114 | $3.2514 | $1.9169 | +10.90% |
| August, 2028 | $9.637 | $0.1536 | $11.14 | +280.16% |
| September, 2028 | $7.0637 | $1.9338 | $14.01 | +178.65% |
| October, 2028 | $2.9505 | $0.3029 | $11.64 | +16.39% |
| November, 2028 | $0.2811 | $1.7761 | $5.2422 | -88.91% |
| December, 2028 | $4.0957 | $0.5427 | $6.0957 | +61.57% |
C 4 Therapeutics Inc Stock (CCCC) Price Forecast for 2029
The 2029 price forecast for C 4 Therapeutics Inc Stock (CCCC) is $10.76 on average, with a high prediction of $20.86 and a low estimate of $0.6686. This represents an +324.58% increase from the previous price of $2.535.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $5.6441 | $3.0507 | $10.91 | +122.65% |
| February, 2029 | $9.2209 | $4.7192 | $9.3609 | +263.74% |
| March, 2029 | $9.7976 | $3.6659 | $16.09 | +286.49% |
| April, 2029 | $18.41 | $8.736 | $19.43 | +626.41% |
| May, 2029 | $12.24 | $11.95 | $20.86 | +382.95% |
| June, 2029 | $15.72 | $10.74 | $17.98 | +520.10% |
| July, 2029 | $8.2163 | $6.4863 | $19.45 | +224.11% |
| August, 2029 | $3.9547 | $0.6686 | $9.4097 | +56.01% |
| September, 2029 | $5.3885 | $1.7236 | $5.6464 | +112.56% |
| October, 2029 | $4.3001 | $4.9434 | $4.1701 | +69.63% |
| November, 2029 | $2.2933 | $4.7684 | $3.4317 | -9.53% |
| December, 2029 | $14.69 | $1.9483 | $0.9183 | +479.35% |
C 4 Therapeutics Inc Stock (CCCC) Price Forecast for 2030
C 4 Therapeutics Inc Stock (CCCC) is expected to reach an average price of $15.47 in 2030, with a high forecast of $18.81 and a low forecast of $12.13. This signifies an +510.27% surge from the last price of $2.535.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $18.20 | $17.32 | $16.88 | +617.87% |
| February, 2030 | $17.89 | $17.96 | $18.01 | +605.77% |
| March, 2030 | $16.75 | $17.58 | $18.81 | +560.93% |
| April, 2030 | $13.50 | $14.43 | $16.08 | +432.46% |
| May, 2030 | $12.16 | $12.13 | $12.88 | +379.66% |
| June, 2030 | $12.76 | $13.02 | $12.51 | +403.46% |
| July, 2030 | $13.21 | $13.90 | $13.58 | +421.27% |
| August, 2030 | $12.36 | $12.38 | $12.18 | +387.48% |
| September, 2030 | $12.31 | $12.43 | $12.30 | +385.63% |
| October, 2030 | $13.49 | $13.20 | $14.25 | +432.24% |
| November, 2030 | $11.90 | $12.14 | $11.63 | +369.25% |
| December, 2030 | $13.83 | $12.71 | $13.12 | +445.52% |
0.95%
3.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):